Abstract | BACKGROUND: METHODS: Experiment 1: After 1 hour of ischemia, p38 MAP kinase, phosphorylated p38 MAP kinase (active form), histologic changes of the lung, and serum levels of TNF-alpha and IL-1beta were examined. Experiment 2: After 2 hours of reperfusion, arterial oxygen content (PaO(2)) and saturation (SaO(2)), serum TNF-alpha and IL-1beta levels, and histologic changes in the lung were examined. Rats were divided into three groups in Experiment 1. In the control group, a saline solution was administered and, in the FR group, 0.1 mg/kg per hour of FR167653 was administered, intravenously throughout the experiment, beginning 30 minutes before ischemia. In the non-ischemic group, samples were taken soon after thoracotomy. The rats were divided into control and FR groups in Experiment 2. RESULTS: Experiment 1: One hour of ischemia induced almost no changes in the lung or serum cytokine levels. Meanwhile, FR167653 markedly attenuated the expression of phosphorylated p38 MAP kinase. Experiment 2: SaO(2) and PaO(2) were improved, serum cytokines were lower, and lung damage was less extensive in the FR group than in the control group. CONCLUSION:
FR167653 attenuates I/R injury of the lung and this attenuation is associated with suppression of p38 MAP kinase activation.
|
Authors | Y Kawashima, I Takeyoshi, Y Otani, Y Koibuchi, D Yoshinari, T Koyama, M Kobayashi, K Matsumoto, Y Morishita |
Journal | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
(J Heart Lung Transplant)
Vol. 20
Issue 5
Pg. 568-74
(May 2001)
ISSN: 1053-2498 [Print] United States |
PMID | 11343984
(Publication Type: Journal Article)
|
Chemical References |
- Cytokines
- FR 167653
- Immunosuppressive Agents
- Interleukin-1
- Pyrazoles
- Pyridines
- Tumor Necrosis Factor-alpha
- Mitogen-Activated Protein Kinases
- p38 Mitogen-Activated Protein Kinases
|
Topics |
- Animals
- Cytokines
(drug effects)
- Immunosuppressive Agents
(pharmacology)
- Interleukin-1
(blood)
- Ischemia
(prevention & control)
- Lung
(blood supply)
- Male
- Mitogen-Activated Protein Kinases
(analysis, antagonists & inhibitors)
- Models, Animal
- Pyrazoles
(pharmacology)
- Pyridines
(pharmacology)
- Rats
- Rats, Wistar
- Reperfusion Injury
(prevention & control)
- Tumor Necrosis Factor-alpha
(analysis, drug effects)
- p38 Mitogen-Activated Protein Kinases
|